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Purpose/Objective: Many dose-limiting normal tissues in radiotherapy 
display considerable internal organ motion during a course of 
treatment, potentially deteriorating the relations between dose-
volume parameters and morbidity. To address this issue, we have 
previously developed a motion simulation model and validated and 
applied it on the rectum geometries in the planning CT scans in a 
cohort of prostate cancer patients. In this present study we apply this 
model to compare the associations with morbidity of the planned vs. 
motion-inclusive dose distributions in two cohorts of patients 
prospectively followed with respect to a broader spectrum of rectal 
morbidity endpoints. 
Materials and Methods: The patients in the two included cohorts 
(Cohort I: 192 patients; Cohort II:87 patients) were previously treated 
with RT for localised prostate cancer to prescribed doses of 70 vs. 74 
Gy. The dose-response relations for the planned as well as simulated 
motion-inclusive rectal dose-volume histograms (DVHs) were 
associated with six rectal morbidity endpoints (Cohort I: RTOG gastro-
intestinal (GI) toxicity, stool frequency,mucosal loss, tenesmus, 
sphincter control and late rectal bleeding (LRB); Cohort II: LRB). The 
motion-inclusive dose distributions were obtained from simulations of 
small, moderate and large motion magnitudes applied to the planned 
dose distributions, using the previously developed and validated 
model.Additionally the data was evaluated with a probit NTCP model 
using the QUANTEC recommended rectal parameters (TD50=76.9, 
m=0.13, n=0.09).  
Results: Statistically significant associations with the studied 
endpoints were obtained at high doses (> 55Gy) using both the 
planned and the simulated motion-inclusive dose distributions, with 
the strongest associations observed for RTOG GI toxicity and stool 
frequency (Spearman's rank correlation coefficient, Rs=0.13-0.21 and 
Rs=0.14-0.16). Within the high dose region the associations with 
morbidity using the planned or the motion-inclusive DVHs with either 
small or moderate motion magnitudes were stronger than the 
associations seen when simulating large motion. Using the probit NTCP 
model the strongest associations were observed for tenesmus 
(Rs=0.14, p=0.03) and LRB (Rs=0.12, p=0.13). 
Conclusions: Equally strong associations with rectal morbidity were 
observed for high doses (>55 Gy), for the planned dose distributions 
and the simulated dose distributions including small and moderate 
rectal motion. Using a probit model with the QUANTEC recommended 
parameters the strongest significant associations were obtained for 
tenesmus. 
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Purpose/Objective: The Linear-Quadratic (LQ)-based ‘Withers’ iso-
effect formula (WIF) is the standard method for deriving a new 
(tumour) dose prescription such that there is normal-tissue (NT) iso-
effect when changing the fraction size and/or number. However, the 
WIF is invalid unless the NT receives a uniform dose equal to the 
tumour dose, or, the NT response is solely determined by the 
maximum NT dose (100% serial). For parallel/quasi-parallel NTs the 
WIF yields highly conservative hypofractionation prescriptions. Our 
aim was to find a method to calculate NT iso-effective fractionation 
schemes which correctly account for arbitrary NT dose distributions 
and ‘architecture’. 
Materials and Methods: We propose a generalized WIF (gWIF) which 
retains the tumour prescription doses but replaces the intrinsic 
fractionation sensitivity measure (α/β) by a new concept: the normal-
tissue effective fractionation sensitivity, (α/β)NTeff, which takes into 
account both the dose heterogeneity in, and the volume effect of, the 
late-responding normal tissue in question. Assuming a power-law dose-
volume response model, we have derived a closed-form analytical 
expression for (α/β)NTeff which ensures exact NT iso-effect, for an 
arbitrary dose distribution and arbitrary volume-effect parameter n. 
Results: As n is varied, (α/β)NTeff increases from its intrinsic value at n 
= 0 (100% serial NT) to values close to or even exceeding the tumour 
(α/β)T at n = 1 (100% parallel NT), with the highest (α/β)NTeff 
corresponding to highly conformal dose distributions. Assuming an 
intrinsic (α/β)NT = 3 Gy, for two IMRT plans for non-small-cell lung 
tumours, with radiation pneumonitis as endpoint (n = 1), in the 
moderately conformal case (α/β)NTeff = 4.5 Gy, whereas for the highly 
conformal plan we obtained (α/β)NTeff = 8.5 Gy. For three typical SABR 
plans, we obtained values of (α/β)NTeff 7.0 to 8.9 Gy depending on the 
DVHs for the non-involved (paired) lungs. Note that our (α/β)NTeff is 
independent of the choice of fractionation scheme. 
Conclusions: The (α/β)NTeff concept embodies an explicit relationship 
between the degree of NT dose heterogeneity, the volume effect 
associated with the clinical endpoint in question, and the 
fractionation sensitivity. The conventional WIF can be retained for 
exact NT iso-effect calculations simply by replacing the intrinsic 
(α/β)NT by (α/β)NTeff. Situations where hypofractionation can (or 
cannot) be safely applied can now be easily identified. Furthermore, 
should the LQ expression over-predict cell killing at large fraction 
sizes, the predictions of the generalized WIF become even ‘safer’.  
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Purpose/Objective: To compare gross tumor volume (GTV) of 
laryngeal and hypopharyngeal carcinoma delineated on MRI with the 
tumor volume of pathology from laryngectomy specimen. 
Materials and Methods: From 22 patients (mean age, 62.3; range, 52 -
79 years; 20 males and 2 females) with T3 (n=5) or T4 (n=17) 
squamous cell carcinoma of the larynx (5 transglottic-, 6 supraglottic-, 
1 glottic carcinoma) or hypopharynx (n=10), the specimen was 
obtained after total laryngectomy. The sliced specimen was processed 
and 3-D reconstructed according to our pathology validation protocol 
and registered to in vivo MR-images with an accuracy of 3 mm in the 
cartilage skeleton. Hematoxylin-eosin (H&E) stained sections were 
obtained and tumor volume on these sections was delineated by a 
pathologist.  
Prior to laryngectomy, a high-resolution 1.5 Tesla MRI-scan was 
performed in a head-and-shoulder mask with a two-element surface 
receiver coil. T2w images and T1w images before and after injection 
of gadolinium were obtained. The mean time interval between the 
MRI-scan and operation was 10.8 days, range 2-34 days. 
Three experienced head-and-neck specialists (2 radiation oncologists, 
1 radiologist) delineated the GTV on MRI after consensus about 
guidelines according to delineation of the GTV in clinical practice. 
Results: The mean tumor volume (27.1 ml, SD 18.2) delineated by the 
observers were almost doubled compared to tumor volumes 
delineated by the pathologist (15.5 ml, SD 15.3). For all patients, the 
GTV of the observers exceeded the tumor volume of the pathologist 
(figure 1). The GTV’s delineated on MRI included tumor tissue as well 
as non-tumorous tissues e.g.; edema and necrosis, enlarging the GTV 
compared to pathology. To increase accuracy in tumor delineation, a 
study is currently performed in our institute to develop MRI-based 
guidelines for interpretation and delineation of head and neck cancer. 
 
  
Figure 1. The GTV of a T3 hypopharyngeal carcinoma delineated on 
transversal MR-image (1a: T1-weighted+gadolinium, 1b: T1-
weigthedand 1c: T2-weighted) by three observers. MR-images are 
registered to the transversal gross-pathology photos (2a) and 
transversal H&E-stained sections(2b) of the same tumor on which true 
tumor is indicated. 
Conclusions: Gross tumor volume on MRI is overestimated in clinical 
radiotherapy practice compared to tumor volume of the pathology.  
